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There is compelling evidence demonstrating a gut-microbiome-
brain connection linking the enteric microbiome to modulations in
human health and behavior, as well as regulation of gut motility, nutri-
ent absorption, immune system, and fat distribution (Cryan and Dinan,
2012, Backhed et al., 2005, Lee and Mazmanian, 2010). Further, the
microbiome plays a role in several disorders including autism, anxiety,
and depression (Cryan and Dinan, 2012, Bravo et al., 2011). Studies in
mice elucidated a few of these roles: improved behavior (Hsiao et al.,
2013), reduction in levels of hormones linked to stress (Desbonnet et
al., 2010, Bravo et al., 2011), increased cognitive performance
(Backhed et al., 2005), and modulation of brain control of emotion
and sensation (Tillisch et al., 2013). These studies point out to the gut
microbiota being a virtual endocrine organ, manipulating and produc-
ing hormones and neurotransmitters that inﬂuence the host's brain
and behavior (Clarke et al., 2014).
Key to unlocking the role of the gutmicrobiome is to understand the
interactions with its environment. More than 90% of the body's mono-
amine serotonin is synthesized by gut enterochromafﬁn cells (Berger).
. This is an open access article underet al., 2009). However, themolecularmechanism that dictates the levels
of serotonin produced and its metabolism is not fully elucidated. This is
of utmost importance given that gut-derived serotonin is responsible
for regulation of functions such as bone development, immune re-
sponses, gut motility, and platelet aggregation (Berger et al., 2009). Per-
hapsmore interesting is the role that dysregulation of serotonin plays in
the pathogenesis of certain intestinal diseases such as irritable bowel
syndrome (IBS). IBS has been shown to have a microbial etiology
(Knights et al., 2013, Jeffery et al., 2012) and as such, the link between
the microbiome and serotonin is of interest. Two hypotheses have
been formulated regarding the microbiome's contribution to serotonin
levels in the host. The ﬁrst relates to the fact that some species of bacte-
ria, such as Escherichia coli and Streptococcus species, are capable of de
novo serotonin synthesis (Lyte, 2013). The second hypothesis states
that the microbiome inﬂuences the biosynthesis of serotonin by the
host (Yano et al., 2015). Indigenous gut bacteria are able to regulate pe-
ripheral host serotonin biosynthesis by interactions with the intestinal
enterochromafﬁn cells (Yano et al., 2015). Further, the microbiota
plays a role in the regulation of central nervous system serotonergic
neurotransmission proﬁles in a sex-dependent manner (Clarke et al.,
2013). It has been also demonstrated that germ free mice synthesize
lower levels of serotonin and its metabolites (Marcobal et al., 2013), in-
dicating that the microbiome is an important factor for the synthesis of
serotonin.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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synthesis, very little is understood regarding why, how, and what are
the consequences of the microbiome's inﬂuence on the host's neuro-
transmitter levels and its manipulation, and vice versa. Most studies
focus on the inﬂuence of the microbiome on changes to the host's pro-
duction of these molecules, while very few examine the effects these
molecules have on bacteria. It was observed that serotonin was able to
stimulate growth of speciﬁc bacteria in culture (Oleskin et al., 1998),
and some virulent bacteria can use neurotransmitters such as epineph-
rine andnorepinephrine to activate virulence genes (Clarke et al., 2006).
Both of these phenomena are linked to bacterial quorum sensing (QS),
which is, in bacteria, a phenomenon when populations reach a speciﬁc
threshold they communicate with organisms in their surroundings by
releasing small diffusible quorum sensing molecules (QSMs). The
QSMs then bind to regulatory proteins, causing a conformational change
and allowing the protein to bind to DNA and initiate the transcription of
virulence factors (Fig. 1). Herein, we hypothesized that bacteria are able
to interactwith host serotoninmolecules and exploit themas a bacterial
QSMs. Speciﬁcally, through experiments conducted in vitro and in vivo
in animal studies, we demonstrate for the ﬁrst time that serotonin acts
as a signalingmolecule for the las regulatory QS system of Pseudomonas
aeruginosa inducing, among other effects, serious pathogenicity in the
host. P. aeruginosa has awell-studied QS network that relies onmultiple
QS pathways critical in activating Pseudomonas virulence including the
las and rhl systems. This work helps explains how high levels of seroto-
nin found in the gut, produced endogenously or by bacteria, can be
linked to the host's health.2. Materials and Methods
2.1. Plasmids and Bacterial Strains
For the whole-cell bioassays, E. coli DH5α cells harboring pSB1075
and pSB904, for LasR and RhlR production, respectively, were used.Fig. 1. Bacterial quorum sensing and quorum sensingmolecule detection. (a) Quorum sensingm
regulatory protein complex activates transcription of virulence factors, such as bioﬁlm formatio
regulatory proteins and corresponding promoter regions in a bacterial plasmid based system
corresponding promoter region that is fused to a reporter protein, such as bacterial lucifer
plasmid is then expressed in a strain of bacteria that does not generate the QSM of interest.Native P. aeruginosa strain PAO-1 and the lasI and rhlI double mutant,
JP2, were supplied by Dr. Johanna Schwingel.
2.2. Dose-response curves for LasR and serotonin
Dose-response curves to determine response to analyte and compet-
itive assays were generated as previously described (Kumari et al.,
2006).
2.3. Elastase Studies
Elastase production was measured using a previously established
protocol with minor adjustments (Smith et al., 2003). P. aeruginosa
PAO1 cells and JP2 cells were grown overnight in LB broth at 37 °C
and 250 rpm. The cells were then diluted to an OD600 of 0.05 in fresh
PTSB media and incubated in the presence of either N-3-oxo-C12-HSL
or serotonin for 16 h at 37 °C and 250 rpm. After incubation, the
OD600 of the cells was measured and they were centrifuged to separate
the cells from the supernatant. The supernatant was then added to
tubes containing 25 mg of Elastin congo red and a 20 mM Tris, 1 mM
CaCl2 buffer and incubated overnight at 37 °C and 250 rpm. The reaction
was then quenched with EDTA and the tubes were then centrifuged to
remove unreacted Congo red-elastin and the absorbance of the super-
natantwasmeasured at 495 nm. All absorbance valueswere normalized
to the OD600 values in order to correct for the variations of cell growth.
2.4. Protease Studies
To measure proteolytic activity, 3 mL of supernatant from an over-
night culture of PAO1 or JP2 cells were added to 10 mM Tris HCl buffer,
pH 7.5 and incubated with 15 mg of Hide powder at 37 ° C for 1 h at
250 rpm. Undissolved substrate was removed by centrifugation at
3000g for 10 min and the absorbance of the supernatant was measured
at 595 nm.olecules (QSMs) enter the bacterial cell and bind to speciﬁc regulatory proteins. TheQSM-
n, as well as production of more QSMs. (b) QSMs can be detected by employing the native
. The plasmid consists of a regulatory protein that is constitutively expressed and the
ase. This allows for dose-dependent generation of signal when QSMs are present. The
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P. aeruginosa strain PAO1 and JP2 were grown overnight in LB broth
at 37 °C and 250 rpm. The culture was then diluted 100-fold inM9min-
imal media supplemented with 0.5% (weight per volume) casamino
acids, 11.1 mM glucose, and 1 mM MgSO4. Next, 1.0 mL solutions of
cells containing either the analytes or the appropriate blanks were pre-
pared according to table S1. Then, 200 μL of each solutionwas placed on
poly-L-lysine coated microscope slides which was then placed in
100 mm petri dishes. A humidity chamber was created by placing a
35mmpetri dish ﬁlled with 5mL of water in the larger dish and sealing
with paraﬁlm. The dishes were then incubated at 37 °C for 16 hwithout
shaking. After incubation, the slides were gently washed with double
distilled deionized water and imaged using a scanning electron
microscope.
2.6. Crystal Violet Bioﬁlm Studies
P. aeruginosa strain PAO-1 and JP2were grown overnight in LB broth
at 37 °C and 250 rpm. The culture was then diluted 100-fold inM9min-
imal media supplemented with 0.5% (weight per volume) casamino
acids, 11.1 mM glucose, and 1 mMMgSO4. Next, 125 μL of each dilution
was added in triplicate to the wells of a 96-well ﬂat-bottomed, white
microtiter plate. The plate was then covered and incubated overnight
at 37 °C in a humidity chamber. After incubation, the plates were
inverted to remove any non-adhering cells. The plate was then washed
three times by submerging the whole plate into container ﬁlled with
double distilled, deionized water and inverting after each wash. Then,
a 0.1% aqueous solution of crystal violet was added to each well and in-
cubated for 15 min at room temperature. The plates were then washed
three times, as described above, to remove any excess crystal violet.
After drying overnight in open air at room temperature, 125 μL of a
30% acetic acid solution was added to each well and incubated 15 min
to dissolve the crystal violet. The resultant solution was transferred to
a clear, ﬂat-bottomed microtiter plate and the absorbance was mea-
sured at 550 nm using an absorbance reader (PolarStar Optima). All
values were blank subtracted using 30% acetic acid as the blank.
2.7. Establishment of Mouse Model of PA Induced Intestinal Infection
Pregnant (E15) C57BL/6 mice were purchased from Charles Rivers
Laboratory and were housed according to NIH guidelines, with one
pregnant female per cage and corncob bedding. Enrichment of nestlets
and sunﬂower seeds were provided when the animals were received
to help acclimate them to the facility. Animals were kept in an Animal
Biosafety Level 2 (ABSL) facility. The entire litter from each pregnant fe-
male (~6 mouse pups) was used for the experimental condition, with
experimental conditions assigned at random. Samples collected were
then blinded before being sent for subsequent analysis. The Institutional
Animal Care and Use Committee (IACUC) of the University of Miami ap-
proved all animal procedures (protocol 15-177). Infections, intraperito-
neal (IP) injections, and sacriﬁcing animals were performed in the
mornings at approximately 10:00 am within the ABSL2 facility. Three
days post birth, the pups were orally inoculated with 103, 104, or
105 CFUs of PAO1 or PBS. Blood was taken from a facial vein every
other day for three days, at which time the pups were sacriﬁced and
their intestines were harvested. Intestinal homogenates were plated
on cetrimide agar plates and incubated at 37 °C. After over-night incuba-
tion, the colony forming units (CFUs) were counted and normalized to
the mass of the intestines.
2.8. Serotonin Effects In Vivo
Serotonin (20 mg/kg) or PBS was administered via intraperitoneal
injection (IP) 1 day post infection. On the third day, the mice weresacriﬁced and the intestines were removed and plated on cetrimide
agar plates to determine colony counts and cytokine levels.
2.9. Histopathological Examination
The intestinal tissues harvested from mice were ﬁxed in formalin,
cut and stained with H&E (Mittal et al., 2009). Intestinal sections were
graded microscopically by a pathologist blinded to groups from grade
0 (normal) to grade 4 (severe) based on pathological manifestations in-
cluding submucosal edema, villus core edema, epithelial sloughing and
obliteration, immune cell inﬁltration, intestinal perforation, and necro-
sis (Mittal et al., 2009).
2.10. Scanning Electron Microscopy (SEM)
Intestines harvested from the mice were washed in PBS and then
ﬁxed in 2% glutaraldehyde in PBS buffer followed by three changes of
PBS buffer for 10 min each. The samples were then post–ﬁxed in 1% os-
mium tetroxide in PBS buffer for 45 min and rinsed in three changes of
PBS buffer for 10 min each. The samples were dehydrated in a graded
series of ethanol, dried in hexamethyldisilazane (HMDS) and mounted
on carbon adhesive tabs ﬁxed to metal stubs. The samples were coated
with palladium in a plasma sputter coater and viewed in a scanning
electron microscope (FEI, ESEM-FEG XL-30).
2.11. Determination of Myeloperoxidase (MPO), Lactate Dehydrogenase
(LDH), Malonaldehyde (MDA), Gluthathione (GSH) and Catalase
The levels of MPO, LDH, MDA, GSH and catalase were determined in
the intestinal homogenates using commercially available kits from
Biovision and Cayman Chemical as per manufacturer's instructions.
2.12. Cytokine Determination
The levels of TNF-α, IL-1β, IL-6 and IL-12 were measured in intesti-
nal homogenates using antibody pair kits from Life Technologies (Carls-
bad, CA) according to the manufacturer's instructions.
2.13. Serotonin Determination
The levels of serotoninwasmeasured in intestinal homogenates and
stool samples via ELISA from Enzo Life Sciences, Inc. (Farmingdale, NY)
according to the manufacturer's instructions.
3. Results
3.1. Serotonin Enhances Virulence of P. aeruginosa in Mice
To understand the effect of serotonin on bacterial infection in vivo,
we established a P. aeruginosa intestinal infection mouse model by
feeding three-day old C57BL/6 mice with wild-type PAO1 cells.
Three-day old mice were employed in this study because they are
naturally susceptible to Pseudomonas infection without the use of
immunocomprimising compounds that could interfere with the study.
Mice were orally inoculated with 103, 104, or 105 CFUs of wild-type P.
aeruginosa (PAO1) or PBS, were sacriﬁced three days post infection,
and the intestines were harvested, homogenized, and plated on
cetrimide agar to determine bacterial load (Fig. S1A). 104 CFUs was se-
lected for use in our mouse model due to it establishing infection 24 h
post oral inoculation (Fig. S1B) and limited mortality (Fig. S1C). Exoge-
nous serotonin was then administered via intraperitoneal injection to
the infected mice revealing an increase in intestinal bacterial load and
mortality compared to untreated animals (Fig. S1C–D). This was con-
ﬁrmed with SEM imaging of the mouse intestines, showing an increase
in bioﬁlm formation when serotonin was administered (Fig. 2A). Histo-
pathological examination of the intestinal tissue showed that in
Fig. 2. Serotonin enhances virulence of P. aeruginosa inmice. (A) Three-day old mice were fed orally with 104 CFU's of PAO1. SEM images of mice intestines inoculatedwith (a) PAO1 cells
and PBS, and (b) PAO1 cells and serotonin. Arrows indicate bioﬁlm formation on intestinal tissues. Scale bars represent 10 μm. (B) Intestines were harvested and subjected to
histopathological examination after staining with H&E. Uninfected control mice fed with (a) PBS had no changes to the intestinal tissue. PAO1 infected mice treated with (b) PBS
showed loss of villi and some epithelial damage as indicated by the arrows. This intestinal tissue damage was further exacerbated in (c) animals infected with PAO1cells and treated
with serotonin showing complete destruction of villi and severe epithelial damage. (C) Intestinal sections were scored for disease severity by a pathologist blinded to specimen.
Signiﬁcant tissue damage was observed in mice infected with bacteria and treated with serotonin (red bar) compared to mice infected with only bacteria (blue bar). Tissue damage
and oxidative stress markers (D) catalase, (E) MDA, (F) LDH, and (G) GSH were determined in intestinal tissue homogenates both in the absence (blue bar) and presence (red bar) of
serotonin. (H) Recruitment of immune cells was examined by MPO activity. (I) The levels of TNFα, IL-1β, IL-12, and IL-6 were determined in intestinal tissues of infected and
uninfected (control) mice by ELISA. The levels of cytokines were signiﬁcantly higher in serotonin treated animals (red bars) compared to untreated mice (blue bars). In all cases, data
represents mean ± SD. Results are representative of 2 independent experiments with a minimum of 4 mice per group. **P b 0.001 or ***P b 0.0001 by ANOVA.
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damage, both in the presence and absence of serotonin (Fig. 2B(a)).
PAO1 infection resulted in intestinal epithelial damage and villi destruc-
tion (Fig. 2B(b)) and the administration of serotonin exacerbated these
effects, demonstrating complete villi destruction, severe epithelialdamage, increased intraepithelial inﬂammatory cells, and degenerative
changes to the base of the crypts (Fig. 2B(c)). The intestinal sections
were then scored via a blinded pathology review, which conﬁrmed se-
vere epithelial injury, mucosal sloughing and villi destruction in mice
administered serotonin as compared to the other groups (Mittal et al.,
Fig. 3. Serotonin acts as a QSM. (a) Dose-response curve for N-3-oxo-C12-HSL of E. coli
cells harboring pSB1075. (b) Dose-response curve for serotonin using E. coli cells
harboring pSB1075. Serotonin activates the LasR regulatory protein at μM
concentrations. (c) Response of E. coli cells harboring pSB1075 when incubated with
QSM at a constant concentration of 0.1 nM and varied serotonin concentrations (red)
and serotonin alone (blue). The dotted line represents the signal from the QSM alone. In
all cases, data represents mean ± SD.
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testinal contentwere assessed via ELISA, which revealed peak serotonin
levels 8 h post IP injection (Fig. S1E\\F). To further conﬁrm ourﬁndings,
we assessed the effect of markers of tissue damage (lactate dehydroge-
nase, LDH, and malondialdehyde, MDA) and oxidative stress (catalase
and glutathione, GSH) in intestinal tissue homogenates. The groups
that were administered serotonin showed signiﬁcantly increased levels
of LDH and MDA, while the levels of catalase and GSH were decreased
(Fig. 2D–G), thus suggesting exacerbation of oxidative stress and tissue
damage (Odobasic et al., 2007) in the presence of serotonin. There was
signiﬁcantly higher recruitment of immune cells in infectionswhere se-
rotonin was present indicated by myeloperoxidase (MPO) levels, sug-
gesting heightened inﬂammation (Fig. 2H).
The aforementioned observations demonstrate that serotonin af-
fects PAO1 infectivity on a macroscopic scale. To investigate the viru-
lence on a biochemical scale, the levels of TNFα, IL-1β, IL-12, and IL-6
in intestinal tissues of sacriﬁced mice were evaluated: these cytokines
have been shown to play an important role in P. aeruginosa infections
(Zhang et al., 2005). The concentrations of all these cytokines were sig-
niﬁcantly elevated in infected mice when serotonin was administered
(Fig. 2I), correlating with the aforementioned intestinal damage.
3.2. Serotonin Acts as a Quorum Sensing Molecule
To elucidate serotonin's role in bacterial communication, we
employed a cellular system that, upon activation by exogenous bacterial
QSMs, elicits a quantiﬁable production of bioluminescence (Fig. 3a). Due
to the complex nature of P. aeruginosa's QS pathways, an E. coli system
was chosen to perform these studies to better isolatewhich speciﬁc pro-
tein serotonin was able to interact with and produce the virulence phe-
notypes noted in the above studies in the native organism. Speciﬁcally,
serotonin's effect on two bacterial communication pathways in P.
aeruginosa, the las and rhl pathway, was assessed. Serotonin elicited a
response from the las QS cellular system at μM concentrations (Fig.
3b). No response was noted in the rhl cellular system, indicating speci-
ﬁcity for the las QS pathway (data not shown). Additionally, we exam-
ined the effects of serotonin on the las QS cellular system in the
presence of las activating QSMs. Serotonin had an additive response
when present with QSMs as compared to serotonin alone (Fig. 3c).
Serotonin is biosynthesized by the metabolism of the essential
amino acid tryptophan (O'mahony et al., 2015). Due to subtle structural
modiﬁcations of molecules during this process, it is important to evalu-
ate the efﬁcacy of precursor molecules in serotonin's synthesis as QSM.
Employing the same cellular system, it was found that these precursor
molecules in the tryptophan metabolic pathway were unable to cause
a response comparable to serotonin (Fig. S2), demonstrating a selectiv-
ity of the LasR protein for serotonin.
3.3. Serotonin Enhances Virulence Phenotypes in P. aeruginosa
While the data indicate that serotonin does interact with the LasR
regulatory protein, it is still important to determine if the presence of se-
rotonin enhances virulence phenotypes in P. aeruginosa. To this end, the
effects of serotonin on the native organismwere evaluated bymonitor-
ing production of elastase, protease, and bioﬁlm formation, all of which
depend on the las QS circuit (Pearson et al., 1997, Davies et al., 1998).
Furthermore, to ensure that the effects were due to interactions with
QS, a lasI mutant strain of P. aeruginosa, JP2, was employed: this strain
is a virulent and lacks the synthase for QSMs (De Kievit et al., 2001).
Thus, JP2 cells are able to re-establish virulence only in the presence of
exogenous molecules that can bind to and activate the LasR protein. In
the presence of serotonin, there were signiﬁcant increases in the pro-
duction of elastase and protease in both PAO1 and JP2 cells (Fig. 4A–
B). Bioﬁlm formation, the mediator of on-set of pathogenicity in the
hosts, was also evaluated. We observed that JP2 cells only formed
bioﬁlms when serotonin, QSM or both were present (Fig. 4C(a–b)).PAO1 cells also demonstrated increased bioﬁlm formation in the pres-
ence of serotonin (Fig. 4C(c–d)). Crystal violet assays further conﬁrmed
these results showing higher bioﬁlm formation in the presence of sero-
tonin for both strains (Fig. 4D).
We also examined two P. aeruginosa phenotypes non-dependent on
the las pathway, namely, swarming motility and lipopolysaccharide
(LPS) production (De Kievit et al., 2001, Beatson et al., 2002). There
was no increase in either upon addition of serotonin (data not shown).3.4. Serotonin Restores Virulence In Vivo in P. aeruginosa QSM Mutant
After establishing that serotonin can mimic QSMs in vitro in Pseudo-
monas, we wanted to elucidate the effects serotonin would have on the
JP2 strain in vivo. The administration of a 104 CFU bolus of the avirulent
Fig. 4. Serotonin enhances virulence phenotypes in P. aeruginosa. (A) JP2 cells were employed to evaluate serotonin's ability to activate QS gene regulation in the native organism. The
presence of serotonin (red bars) was able to signiﬁcantly enhance elastase synthesis in PAO1 cells and activate elastase synthesis in JP2 cells as opposed to the bacteria alone (blue
bars) (averages (n = 3) ± one standard deviation). Serotonin (red bars) increased production of (B) protease in both PAO1 and JP2 cells. (C) Bioﬁlm development in the presence and
absence of serotonin. (a) JP2 cells only formed bioﬁlms in (b) serotonin's presence while (c) PAO1 cells bioﬁlm formation increased with the addition of (d) serotonin. Scale bars
represent 10 μm. (D) Crystal violet assay conﬁrmed bioﬁlm formation in PAO1 cells and JP2 cells in the absence (blue bars) and presence (red bars) of serotonin. In all cases, data
represents mean ± SD and is representative of ﬁve individual experiments carried out in triplicate. *P b 0.05 or **P b 0.001 or ***P b 0.0001 by ANOVA.
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(Fig. S3A). When serotonin was administered, there was only a 50%
(4/8) survival after three days. This correlates with an increase in CFUs
of JP2 in the presence of serotonin (Fig. S3B). This increase in coloniza-
tion was conﬁrmed via SEM imaging of the intestinal tissue (Fig. 5A).
Histopathological examination showed that tissue from mice infected
with JP2 was similar to the negative control (Fig. S1H) while tissue
from mice infected with JP2 and dosed with serotonin showed villi de-
struction and epithelial injury (Fig. 5B) very similar to that observed of
PAO1 infected mice (Fig. 2B). Additionally, tissue from JP2 infection inthe presence of exogenous serotonin was scored similarly to PAO1 in-
fection in the absence of exogenous serotonin (Fig. 5C), indicating that
serotonin is able to restore the pathogenicity of JP2 cells. We also
assessed markers of tissue damage (lactate dehydrogenase, LDH and
malondialdehyde, MDA) and oxidative stress (catalase and glutathione,
GSH) in intestinal tissue homogenates. The groups that were adminis-
tered serotonin showed signiﬁcantly increased levels of MDA, while
the levels of catalase and GSH were signiﬁcantly decreased (Fig. 5D–
G), thus suggesting exacerbation of oxidative stress and tissue damage
(Odobasic et al., 2007) in the presence of serotonin. There was
Fig. 5. serotonin restores virulence in vivo in P. aeruginosa QSM mutant. (A) SEM images of mice intestines inoculated with (a) JP2 cells and PBS, and (b) JP2 cells and serotonin. Arrows
indicate bioﬁlm formation on intestinal tissues. Scale bars represent 10 μm. (B) Intestines were harvested and subjected to histopathological examination after staining with H&E.
Uninfected control mice fed with (a) PBS and mice infected with (b) JP2 and fed PBS had no changes to the intestinal tissue. JP2 infected mice treated with (c) serotonin showed loss
of villi and some epithelial damage as indicated by the arrows. (C) Intestinal sections were scored for disease severity by a pathologist blinded to specimen. Signiﬁcant tissue damage
was observed in mice infected with bacteria and treated with serotonin (red bars) as compared to mice infected only with the bacteria (blue bars). Tissue damage and oxidative stress
markers (D) catalase, (E) MDA, (F) LDH, and (G) GSH were determined in intestinal tissue homogenates both in the absence (blue bars) and presence (red bars) of serotonin. (H)
Recruitment of immune cells was examined by MPO activity. (I) The levels of TNFα, IL-1β, IL-12, and IL-6 were determined in intestinal tissues of infected mice in the absence (blue
bars) and presence (red bars) of serotonin by ELISA. In all cases, data represents mean ± SD. Results are representative of 2 independent experiments with a minimum of 4 mice per
group. **P b 0.001 or ***P b 0.0001 by ANOVA.
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rotonin was present indicated by myeloperoxidase (MPO) levels, sug-
gesting heightened inﬂammation (Fig. 5H). Further, in the presence of
serotonin, JP2 infection signiﬁcantly enhanced the production of the cy-
tokines TNFα, IL-1β, IL-12, and IL-6 (Fig. 5I).4. Discussion
This study establishes serotonin's role as a bacterial quorum sensing
molecule. Our cellular system data show that serotonin can activate the
LasR QS pathway at μM concentrations (Fig. 3b). This ﬁnding is of great
168 L.D. Knecht et al. / EBioMedicine 9 (2016) 161–169interest as physiological levels of serotonin in the digestive tract of
healthy and diseased individuals is 10 μM (Erspamer, 1966) and
~100 μM (Miwa et al., 2001) respectively. The raised levels of serotonin
in patients with Inﬂammatory Bowel Disease (IBD), combined with the
insight that serotonin can activate QS pathways, may allow for better
patient care and therapeutics. Additionally, the additive effects of sero-
tonin combined with QSM (Fig. 3c) are relevant as bacteria exist natu-
rally in the gut, thus it is highly likely that serotonin will co-exist with
bacterial QSMs.
Previous reports have shown that virulence factor production, such
as bioﬁlm formation and protease production, are quorum-dependent
(Waters et al., 2008, Valiente et al., 2007), which supports the increase
in these factors seen when serotonin was administered in both our in
vitro (Fig. 4) and in vivo (Figs. 2, 5) experiments as serotonin activating
the LasR QS system. In vitro, our results show that serotonin mimics the
effects of exogenous QSM addition in JP2 cells' bioﬁlm formation (Fig.
4C–D), indicating that serotonin acts as a bacterial signaling molecule
that is capable of activating QS-regulated phenotypes. Our developed
Pseudomonas infection model demonstrated that serotonin was able to
activate Pseudomonas virulence in vivo, within the intestines of the
mice (Figs. 2, 5). Within these experiments, there are two points of par-
ticular interest: in the absence of serotonin the JP2 mutant that cannot
generate its ownQSMswasnot able to establish an infection, and the ef-
fects of PAO1 infection alonewere similar to the effects of JP2with sero-
tonin. When administered the same CFU of JP2 cells compared to PAO1
cells, the JP2 mutant Pseudomonas did not establish any detectable col-
onies (Fig. S3B). This lack of infection is supported by the SEM images
(Fig. 5A) and histology data (Fig. 5B–C). As the JP2 mutant is only lack-
ing in QSM synthesis, this inability to establish an infection both sup-
ports the current literature that Pseudomonas virulence is QS
dependent and allows for the assessment of restoration of function, spe-
ciﬁcally the ability to establish an infection. Thus when we restore the
infectivity of JP2 by administering serotonin (Fig. S3B), it indicates
that serotonin is fulﬁlling the role of a QSM. The infection with PAO1
alone and JP2with serotonin resulted in similar levels of CFUs harvested
from the intestines (Fig. S1D, S3B), which further supports serotonin's
role as a QSM. This similarity between PAO1 alone and JP2 with seroto-
nin is also noted in the histology data (Figs. 2B–C, 5B–C), with both
exhibiting intestinal epithelial damage and villi destruction. These
data further demonstrate serotonin's ability to restore function to the
JP2 mutant lacking QSMs, providing greater evidence for its role as a
QSM.
Our experiments demonstrate that serotonin activates the las quo-
rum sensing pathway, which leads to greater infectivity of P. aeruginosa,
however continued experimentation with Pseudomonas infection and
serotonin can help to fully elucidate this complex interplay. Our
mouse model was limited due to its focus on three day old mouse
pups based upon their natural susceptibility to Pseudomonas infection,
however, it may be possible to exploit serotonin's enhancement of Pseu-
domonas virulence to investigate Pseudomonas infections in adult mice.
Additionally, there are limitations to current biochemical assays for
QSMs, such as a lack of a full crystal structure for LasR. Advancements
in this ﬁeld will allow for binding studies of serotonin with LasR,
which would further enhance our ﬁndings.
While it is uncertain why Pseudomonas utilizes another organism's
molecules to enhance their QS networks, it is not a novel phenomenon.
Social cheating by bacteria, where the bacteria exploit sensing mole-
cules produced by other organisms in their vicinity to activate their QS
systems, has been observed in many circumstances. Thus serotonin
may be away the opportunistic bacteria P. aeruginosa participates in so-
cial cheating to enhance its virulence. While our knowledge of the
human microbiome is in its nascent stage, the observed Janus-type be-
havior of serotonin, acting as both mammalian neurotransmitter and
bacterial communication molecule, undoubtedly will contribute to fur-
ther our knowledge of the complex relationship between the host and
its' microbiome. Speciﬁcally, these ﬁndings could lead to a betterunderstanding of the host regulation of themicrobiome, especially dur-
ing infection, potentially leading to a paradigm shift in themanagement
of intestinal bacterial-related illnesses or disorders of the digestive sys-
tem that are triggered by bacteria.
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